Advent Life Sciences

Venture capital firm based in London, UK

Advent Life Sciences Investments

Advent Life Sciences has invested in these startups.

Curve Therapeutics

Curve Therapeutics, backed by $40.5M in funding from industry giants like Pfizer Ventures, is revolutionizing drug discovery to tackle complex diseases and push the boundaries of biotechnology. Read more

Epitopea

Biotech

Epitopea secures a £500K grant to revolutionize cancer treatment with cutting-edge immunotherapies targeting hidden antigens—ushering in a new era in the fight against cancer! Read more

Cyted Health

Healthtech

Cyted Health secures $44 million (£33 million) in Series B funding, advancing its game-changing early cancer detection technology. Read more

F2G

Healthtech

"F2G Secures $100 Million to Advance Antifungal Research"

With a groundbreaking $100 million funding boost, Manchester's F2G is set to revolutionize the fight against invasive fungal infections with its pioneering drug, olorofim! Read more

Investments By Sector

Advent Life Sciences has invested in these sectors

Healthtech	60.0%
Biotech	40.0%

Venture Capital Investors

Connect with VC Investors from Advent Life Sciences

Raj Parekh

Kaasim Mahmood

General Partner

Alan Walts

Venture Partner

Shahzad Malik

General Partner

Philomena Lip

Associate

Rowena Patel

Don Drakeman

Venture Partner

They Have Invested With Advent Life Sciences

Connect with investors related to Advent Life Sciences's network

British Business Bank

British Patient Capital

Columbus Venture Partners

Epidarex Capital

List of pre-seed

& seed VC firms

2025 Startupmag.co.uk © Kohdao Ltd. Unit 8B Raleigh Gardens, Brixton, London, SW2 1AD, UK.
Registration 06261702. Data Protection No: ZA891746.

Advent Life Sciences